| Abstrakt: |
The US Federal Trade Commission (FTC) has filed a lawsuit against the three largest pharmacy benefit managers (PBMs) in the country, accusing them of steering patients towards higher-priced insulins to increase profits. The PBMs named in the lawsuit are CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum. The FTC alleges that these PBMs engaged in unfair competition practices, leading to higher insulin prices for patients. Ohio Attorney General Dave Yost had previously sued Express Scripts and Prime Therapeutics for similar antitrust violations. [Extracted from the article] |
